Table I.
Characteristics | Frequency, n (%) |
---|---|
Total | 343 (100%) |
Age, mean (range) years | 64 (29–89) |
Sex | |
Male | 198 (57.7%) |
Female | 145 (42.3%) |
Diabetes mellitus | |
Yes | 68 (19.8%) |
No | 275 (80.2%) |
pT stage | |
T1 | 26 (7.6%) |
T2 | 45 (13.1%) |
T3 | 216 (63.0%) |
T4 | 56 (16.3%) |
pN stage | |
N0 | 218 (63.5%) |
N1 | 81 (23.6%) |
N2 | 44 (12.9%) |
pM stage | |
M0 | 322 (93.8%) |
M1 | 21 (6.2%) |
Tumor location | |
Right | 116 (33.8%) |
Left | 227 (66.2%) |
Tumor size | |
<5 cm | 226 (65.9%) |
≥5 cm | 117 (34.1%) |
Vascular invasion | |
Yes | 54 (15.7%) |
No | 289 (84.3%) |
Lymphatic invasion | |
Yes | 96 (28.0%) |
No | 247 (72.0%) |
Perineural invasion | |
Yes | 116 (33.8%) |
No | 227 (66.2%) |
Differentiation | |
Well/moderately differentiated | 322 (93.9%) |
Poorly differentiated | 21 (6.1%) |
AMPK levels | |
High | 89 (25.9%) |
Low | 254 (74.1%) |
TET2 levels | |
High | 93 (27.1%) |
Low | 250 (72.9%) |
T, tumor; N, node; M, metastasis; AMPK, AMP-activated protein kinase; TET2, ten eleven translocation 2.